| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 12/18/2008 | CA2684886A1 Dual-acting benzoimidazole antihypertensive agents |
| 12/17/2008 | EP2003142A1 Amorphous perindopril erbumine |
| 12/17/2008 | EP2002839A1 Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
| 12/17/2008 | EP2002837A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 12/17/2008 | EP2002734A1 Carbohydrate composition obtainable from mediterranean fruits |
| 12/17/2008 | EP2001866A2 Organic compounds |
| 12/17/2008 | EP2001856A1 Crystalline forms of n- {2-tert -butyl -1- [ (4,4- dif luorocyclohexyl) methyl]-lh-benzimidazol-5- yl}ethanesulfonamide salts |
| 12/17/2008 | EP2001851A2 Amide derivatives and their application for the treament of g protein related diseases |
| 12/17/2008 | EP2001838A2 Selective hydroxamate based mmp inhibitors |
| 12/17/2008 | EP2001505A2 Cathepsin propeptide and uses thereof |
| 12/17/2008 | EP2001484A2 Methods and compositions for treating hypercholesterolemia and atherosclerosis |
| 12/17/2008 | EP2001483A1 Use of cholest-4-in-3-in-one derivatives to obtain a cytoprotective medicine |
| 12/17/2008 | EP2001466A2 Formulations and methods for vascular permeability-related diseases or conditions |
| 12/17/2008 | EP1843791A4 Treatment of degenerative diseases with the x-linked inhibitor of apoptosis |
| 12/17/2008 | EP1742950B1 Pyrazolo[4,3-d] pyrimidines |
| 12/17/2008 | EP1536778B1 Proteins binding to cross-beta structure comprising amyloid and methods for modulation of the cross-beta structure, its formation and its associated toxicity |
| 12/17/2008 | EP1425001B1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 12/17/2008 | EP1377284B1 Controlled release arginine formulations |
| 12/17/2008 | EP1330244B1 Compositions comprising modafinil compounds |
| 12/17/2008 | EP1255742B1 2-thio-4h-3,1-benzoxazin-4-one derivatives for use as enzyme inhibitors |
| 12/17/2008 | EP1077943B1 Heterocyclic inhibitors of p38 |
| 12/17/2008 | CN101326181A Imidazopyridine derivatives as a2b adenosine receptor antagonists |
| 12/17/2008 | CN101325964A Vip片段和应用方法 Vip fragments and application methods |
| 12/17/2008 | CN101323850A Lactobacillus helveticus microcapsule, preparation and use thereof |
| 12/17/2008 | CN101323634A Induced nuclear receptor TR3 expressed cardiac glycoside compounds and use thereof |
| 12/17/2008 | CN101323613A Berberine additive product, medicament containing the same and preparation thereof |
| 12/17/2008 | CN101323604A Novel PPAR alpha/beta dual agonist, preparation and use thereof |
| 12/17/2008 | CN101322840A Human cystathionine beta-synthetase recombinant protein and use |
| 12/17/2008 | CN101322801A Use of Chinese medicinal composition in preparing medicament for treating dilated cardiomyopathy |
| 12/17/2008 | CN101322792A Applications of Chinese medicinal composition in preparing medicament for improving function of vascular endothelium |
| 12/17/2008 | CN101322780A Formulation for delaying aging, improving cardiovascular and cerebrovascular condition, and prolonging life and preparation thereof |
| 12/17/2008 | CN101322737A Persimmon leaf flavones extract and preparation thereof |
| 12/17/2008 | CN101322716A Applications of anthocyanin and regulation for CHOP gene in preventing and treating atherosclerosis |
| 12/17/2008 | CN101322713A Applications of gastrodine in preparing cysteine proteinase-3 active inhibitor |
| 12/17/2008 | CN101322712A Alprostadil nano granule formulation and preparation thereof |
| 12/17/2008 | CN101322710A Levosimendan emulsion for intravenous injection and preparation thereof |
| 12/17/2008 | CN101322687A Adenosine cyclophosphate oil in water composition for vein and preparation thereof |
| 12/17/2008 | CN101322607A Chinese tea health-care pillow |
| 12/17/2008 | CN101322556A Tibetan medicine anti-fatigue anoxia-tolerance drink |
| 12/17/2008 | CN101322514A Green tea Ganoderma lucidum drink and preparation method thereof |
| 12/17/2008 | CN100443493C Process of preparing burdock glucoside and glucosidgen thereof |
| 12/17/2008 | CN100443479C 2-arylimino-2,3-dihydothiazoles, and their use thereof as somatostain receptor ligands |
| 12/17/2008 | CN100443477C Substituted benzoxazoles and analogues as estrogenic agents |
| 12/17/2008 | CN100443119C Inhalation of nitric oxide |
| 12/17/2008 | CN100443095C Compound formulation of breviscapine and asarum herb for treating cardiovascular and cerebrovascular diseases and its application |
| 12/17/2008 | CN100443094C Oral Chinese medicinal composition for treating apoplexia |
| 12/17/2008 | CN100443084C Alprostadil preparation and its making method |
| 12/17/2008 | CN100443075C 'Sheng Mai' drop pills and preparation method thereof |
| 12/17/2008 | CN100443001C Health tea drink of Aizoon stonecrop herb |
| 12/16/2008 | US7465737 Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl -6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives |
| 12/16/2008 | US7465736 e.g. (2-chloropyrimidin-4-yl)-(4-ethyl-3H-thiazol-2ylidene)-acetonitrile,[4-(4-chlorophenyl)-1,3-thiazol-2(3H)-ylidene](2-chloropyrimidin-4-yl)acetonitrile; Jun N-terminal kinase and Glycogen Synthase Kinase 3 inhibitor; antidiabetic, antiinflammatory, anticarcinogenic agent; neurodegenerative diseases |
| 12/16/2008 | US7465728 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity |
| 12/16/2008 | US7465718 Ansamycins having improved pharmacological and biological properties |
| 12/16/2008 | US7465713 human SGLT2 (sodium ion / glucose cotransporter 2) inhibitors; antidiabetic and hyperglycemic agents; obesity; 3-(6-O-ethoxycarbonyl- beta -D-glucopyranosyloxy)-4-[(4-isopropoxyphenyl)methy]-1-isopropyl-5-methylpyrazole |
| 12/16/2008 | US7465704 Methods for enhancing healing of diabetic foot ulcers by injecting epidermal growth factor (EGF) |
| 12/16/2008 | US7465548 associated with the disorders of the peripheral and central nervous system, cardiovascular diseases, hematological diseases, cancer, inflammation, urological diseases, respiratory diseases and gastroenterological diseases |
| 12/16/2008 | CA2399377C New positive allosteric ampa receptor modulators (paarm), processes for preparing them and their use as pharmaceutical compositions |
| 12/16/2008 | CA2369739C Compositions and methods for improving integrity of compromised body passageways and cavities |
| 12/16/2008 | CA2295519C A preparation derived from shark cartilage for treatment of diseases related to excessive phf or excessive intracellular calcium |
| 12/16/2008 | CA2285242C Mixture of primary fatty acids obtained from sugar cane wax |
| 12/13/2008 | CA2634563A1 Carbohydrate composition obtainable from mediterranean fruits |
| 12/11/2008 | WO2008150565A2 Ranolazine for elevated brain-type natriuretic peptide |
| 12/11/2008 | WO2008149980A1 Fibrosis inhibitor |
| 12/11/2008 | WO2008149971A1 Therapeutic or prophylactic agent for cerebral aneurysm |
| 12/11/2008 | WO2008149965A1 Pyridone compound |
| 12/11/2008 | WO2008149689A1 Composition having antioxidative activity |
| 12/11/2008 | WO2008149688A1 Composition having antioxidative activity |
| 12/11/2008 | WO2008149177A2 Marine lipid compositions and uses thereof |
| 12/11/2008 | WO2008149160A1 Amorphous olmesartan medoxomil |
| 12/11/2008 | WO2008149155A1 Crystalline form b of olmesartan medoxomil |
| 12/11/2008 | WO2008149115A1 Precursor of tryptophyllin-1 and uses thereof |
| 12/11/2008 | WO2008149053A1 Bicycl0 [2. 2. 1] he pt- 2-ylamine derivates and their use |
| 12/11/2008 | WO2008148849A2 Piperidine/piperazine derivatives |
| 12/11/2008 | WO2008148812A1 5beta, 14beta-androstane derivatives useful for the treatment of restenosis after angioplastic or endoartherectomy and diseases due to organ fibrosis |
| 12/11/2008 | WO2008148359A1 The therapeutic uses of imidazol-5-carboxylic acid derivatives |
| 12/11/2008 | WO2008130953A3 2-imin0is0thiaz0le derivatives as cannabinoid receptor ligands |
| 12/11/2008 | WO2008110356A3 Protein pi 16 secreted from the heart and uses thereof |
| 12/11/2008 | WO2008085074A3 1, 3-dihydroimidazoles for treating cardiovascular disorders |
| 12/11/2008 | WO2008082321A8 Emulsion of perfluoroorganic compounds for medical use and a methods for the preparation and the use thereof |
| 12/11/2008 | WO2008002905A3 Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same |
| 12/11/2008 | WO2007061661A3 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 12/11/2008 | US20080306157 Therapeutic intervention to MIMIC the effect of caloric restriction |
| 12/11/2008 | US20080306154 Treatment and prevention of major adverse cardiovascular events or major coronary evens by administering Omega-3 fatty acids |
| 12/11/2008 | US20080306151 Deuterium-enriched fenofibrate |
| 12/11/2008 | US20080306150 Compounds for the Treatment of Metabolic Disorders |
| 12/11/2008 | US20080306140 Isoflavonoid Dimers |
| 12/11/2008 | US20080306135 Process for the Preparation of Crystalline Perindopril |
| 12/11/2008 | US20080306134 Thalidomide analogs for treating vascular abnormalities |
| 12/11/2008 | US20080306128 new forms of 2-butyl-1-[2'-(1H-tetrazol-5-yl)bifenyl-4-yl-methyl]spiro[2-imidazoline-4.1'-cyclopentane]-5-one; antagonist of angiotensin-II receptors |
| 12/11/2008 | US20080306125 nuclear receptor modulators such as 6-{4-[3-(2,6-Dichloro-phenyl)-5-isopropyl-isoxazol-4-ylmethoxy]-phenyl}-1-isopropyl-1H-indole-3-carboxylic acid, used for treating dyslipidemia, atherosclerosis, diabetes, raising plasma high density lipoproteins, lowering low density lipoproteins and triglycerides |
| 12/11/2008 | US20080306124 Polycyclic Oxadiazoles or I Soxazoles and Their Use as Sip Receptor Ligands |
| 12/11/2008 | US20080306114 Human G Protein-Coupled Receptor and Modulators Thereof for the Treatment of Hyperglycemia and Related Disorders |
| 12/11/2008 | US20080306113 Methods for treating macular degeneration using 4-(amino)-2-(2,6-dioxo(3-piperidyle))-isoindoline-1,3-dione |
| 12/11/2008 | US20080306108 Substituted Pyridoxines As Anti-Platelet Agents |
| 12/11/2008 | US20080306103 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 12/11/2008 | US20080306085 Non-imidazole aryloxyalkylamines |
| 12/11/2008 | US20080306070 Combination Therapy Comprising Substituted Oxazolidinones for the Prevention and Treatment of Cerebral Circulatory Disorders |
| 12/11/2008 | US20080306065 Metalloproteinase Inhibitors |
| 12/11/2008 | US20080306047 Use of Aza-Phenylalanine Compounds For Treating Cardiac Arrhythmia |
| 12/11/2008 | US20080306044 Spirobenzoazepanes as vasopressin antagonists |